Gilead (GILD -0.7%) has a bit of a data dump from studies of its HIV treatments, highlighting...


Gilead (GILD -0.7%) has a bit of a data dump from studies of its HIV treatments, highlighting good performances from elvitegravir, complera and cobicistat. Gilead is presenting the data at the 19th International AIDS Conference in Washington.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs